These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 10452638

  • 1. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex.
    Gordin FM, Sullam PM, Shafran SD, Cohn DL, Wynne B, Paxton L, Perry K, Horsburgh CR.
    Clin Infect Dis; 1999 May; 28(5):1080-5. PubMed ID: 10452638
    [Abstract] [Full Text] [Related]

  • 2. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD, Singer J, Zarowny DP, Phillips P, Salit I, Walmsley SL, Fong IW, Gill MJ, Rachlis AR, Lalonde RG, Fanning MM, Tsoukas CM.
    N Engl J Med; 1996 Aug 08; 335(6):377-83. PubMed ID: 8676931
    [Abstract] [Full Text] [Related]

  • 3. A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS.
    Cohn DL, Fisher EJ, Peng GT, Hodges JS, Chesnut J, Child CC, Franchino B, Gibert CL, El-Sadr W, Hafner R, Korvick J, Ropka M, Heifets L, Clotfelter J, Munroe D, Horsburgh CR.
    Clin Infect Dis; 1999 Jul 08; 29(1):125-33. PubMed ID: 10433575
    [Abstract] [Full Text] [Related]

  • 4. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
    Benson CA, Williams PL, Cohn DL, Becker S, Hojczyk P, Nevin T, Korvick JA, Heifets L, Child CC, Lederman MM, Reichman RC, Powderly WG, Notario GF, Wynne BA, Hafner R.
    J Infect Dis; 2000 Apr 08; 181(4):1289-97. PubMed ID: 10762562
    [Abstract] [Full Text] [Related]

  • 5. Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group.
    Dubé MP, Torriani FJ, See D, Havlir DV, Kemper CA, Leedom JM, Tilles JG, McCutchan JA, Sattler FR.
    Clin Infect Dis; 1999 Jan 08; 28(1):136-8. PubMed ID: 10028084
    [Abstract] [Full Text] [Related]

  • 6. [Uveitis associated with rifabutin treatment. Apropos of 3 patients].
    Chevalley GF, Kaiser L, Bouchenaki N, Baglivo E, Kress O.
    Klin Monbl Augenheilkd; 1995 May 08; 206(5):388-90. PubMed ID: 7609395
    [Abstract] [Full Text] [Related]

  • 7. Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD, Talbot JA, Chomyc S, Davison E, Singer J, Phillips P, Salit I, Walmsley SL, Fong IW, Gill MJ, Rachlis AR, Lalonde RG.
    Clin Infect Dis; 1998 Dec 08; 27(6):1401-5. PubMed ID: 9868650
    [Abstract] [Full Text] [Related]

  • 8. Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. MAC Study Group of the Canadian HIV Trials Network.
    Shafran SD, Deschênes J, Miller M, Phillips P, Toma E.
    N Engl J Med; 1994 Feb 10; 330(6):438-9. PubMed ID: 8284019
    [No Abstract] [Full Text] [Related]

  • 9. Progress report: prophylaxis and therapy for MAC.
    Currier J.
    AIDS Clin Care; 1996 Jun 10; 8(6):45-8. PubMed ID: 11363599
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.
    Pierce M, Crampton S, Henry D, Heifets L, LaMarca A, Montecalvo M, Wormser GP, Jablonowski H, Jemsek J, Cynamon M, Yangco BG, Notario G, Craft JC.
    N Engl J Med; 1996 Aug 08; 335(6):384-91. PubMed ID: 8663871
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rifabutin for MAC questioned.
    Posit Aware; 1995 Aug 08; ():6. PubMed ID: 11362571
    [Abstract] [Full Text] [Related]

  • 14. A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome.
    Benson CA, Williams PL, Currier JS, Holland F, Mahon LF, MacGregor RR, Inderlied CB, Flexner C, Neidig J, Chaisson R, Notario GF, Hafner R, AIDS Clinical Trials Group 223 Protocol Team.
    Clin Infect Dis; 2003 Nov 01; 37(9):1234-43. PubMed ID: 14557969
    [Abstract] [Full Text] [Related]

  • 15. Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV Research Consortium.
    Ward TT, Rimland D, Kauffman C, Huycke M, Evans TG, Heifets L.
    Clin Infect Dis; 1998 Nov 01; 27(5):1278-85. PubMed ID: 9827282
    [Abstract] [Full Text] [Related]

  • 16. Uveitis during treatment of disseminated Mycobacterium avium-intracellulare complex infection with the combination of rifabutin, clarithromycin and ethambutol.
    Lowe SH, Kroon FP, Bollemeyer JG, Stricker BH, van 't Wout JW.
    Neth J Med; 1996 Jun 01; 48(6):211-5. PubMed ID: 8710040
    [Abstract] [Full Text] [Related]

  • 17. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS.
    Nightingale SD, Cameron DW, Gordin FM, Sullam PM, Cohn DL, Chaisson RE, Eron LJ, Sparti PD, Bihari B, Kaufman DL.
    N Engl J Med; 1993 Sep 16; 329(12):828-33. PubMed ID: 8179648
    [Abstract] [Full Text] [Related]

  • 18. [Treatment with clarithromycin of 173 HIV+ patients with disseminated Mycobacterium avium intracellulare infection].
    Dautzenberg B, Saint-Marc T, Durant J, Reynes J, Meyohas MC, Legrand MF, Truffot C, Chauvin JP.
    Rev Mal Respir; 1994 Sep 16; 11(3):271-6. PubMed ID: 8041990
    [Abstract] [Full Text] [Related]

  • 19. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
    Havlir DV, Dubé MP, Sattler FR, Forthal DN, Kemper CA, Dunne MW, Parenti DM, Lavelle JP, White AC, Witt MD, Bozzette SA, McCutchan JA.
    N Engl J Med; 1996 Aug 08; 335(6):392-8. PubMed ID: 8676932
    [Abstract] [Full Text] [Related]

  • 20. Recent development in the treatment and prevention of disseminated Mycobacterium avium complex (MAC).
    Schouten JT, Whittemore S.
    STEP Perspect; 1996 Aug 08; 8(3):5-6. PubMed ID: 11364267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.